NEW YORK (GenomeWeb News) – Bruker announced today an agreement to acquire the preclinical in vivo imaging equipment product portfolio and related assets from Carestream Health's Molecular Imaging business for an undisclosed amount.
The deal is expected to be completed in the next several weeks, Bruker said. The majority of employees in the Carestream business being bought by Bruker are being offered employment with Bruker.
"We believe that Carestream's optical molecular imaging product line will complement our other preclinical solutions, presently consisting of magnetic resonance imaging, magnetic particle imaging, and X-ray micro computed tomography," Werner Maas, president of Bruker BioSpin, said in a statement.
Carestream will keep the remaining assets of the Molecular Imaging business, including its life science X-ray film product lines and its Gel Logic and Image Station in vitro imaging equipment product portfolio, though new production of Gel Logic and Image Station in vitro products are being discontinued.